K-Bro Linen (KBL) Q4 2024 earnings summary

Executive summary

• Reported record annual revenue of CAD 374 million (USD 373.6M) in 2024, up 16.4% year-over-year, with strong growth in both healthcare and hospitality segments.

• Adjusted EBITDA rose to CAD 72.1 million (19.3% margin), reflecting disciplined growth and margin restoration to pre-pandemic levels.

• Completed three acquisitions (Villeray, Shortridge, C.M.) expanding geographic footprint and service capabilities in Canada and the UK.

• Declared $1.20 per common share in dividends for 2024.

Financial highlights

• Healthcare revenue grew 6.2% to $195.8M; hospitality revenue surged 30.3% to $177.8M year-over-year.

• Consolidated Adjusted EBITDA rose 24.2% to CAD 72.1 million, with margin up 1.2% to 19.3% year-over-year.

• Net earnings increased 6.3% to CAD 18.7 million, though net margin declined to 5%.

• Cash from operations was $49.95M, up 21.8% from 2023; distributable cash flow reached $39.6M.

• Long-term debt rose to $123.8M, up 76.2% due to acquisitions.

Outlook and guidance

• Positive outlook for 2025 with focus on organic growth, M&A, and steady volume growth in healthcare and hospitality.

• EBITDA margins anticipated to remain stable, following historical seasonal trends.

• 2025 capital spending planned at $10–12M, prioritizing projects with short-term paybacks and operational efficiency.

• No significant contract renewals expected until 2027; minor renewals in 2025–2026 could total CAD 10 million annually.

• Active M&A pipeline with strong liquidity and access to capital markets to pursue further growth.